Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT200 in Chemotherapy-Refractory Metastatic Colorectal Cancer
NCT03405272Phase 2Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sct200 in metastatic colorectal cancer (mCRC), sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
sct200
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03405272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405272.